Amerigen Seeks Patent Board Review Of Shire ADHD Drug

(January 18, 2017, 10:09 AM EST) -- ALEXANDRIA, Va. — A patented pharmaceutical composition containing three different beads of amphetamine salts is unpatentable pursuant to 35 U.S. Code Sections 102(b) and 103, Amerigen Pharmaceuticals Limited argues in a...

To view the full article, register now.